The Downstream Column (DsC) is an online publication targeting members of the biologics industry. Our intent is to provide a community to share expertise and best practices as well as discuss topics of interest. The Downstream Column covers areas important to the research, discovery, development, and manufacture of biologic therapeutics. Key industry coverage areas include: purification, formulation, fill/finish, and QA/QC for cell and gene therapies, vaccines, biologics, and emerging therapeutic modalities.
All content for The Downstream Column Podcast is the property of Brandy Sargent and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The Downstream Column (DsC) is an online publication targeting members of the biologics industry. Our intent is to provide a community to share expertise and best practices as well as discuss topics of interest. The Downstream Column covers areas important to the research, discovery, development, and manufacture of biologic therapeutics. Key industry coverage areas include: purification, formulation, fill/finish, and QA/QC for cell and gene therapies, vaccines, biologics, and emerging therapeutic modalities.
Start With The End In Mind. How to facilitate transfer from non-GMP to GMP Manufacturing
The Downstream Column Podcast
14 minutes 13 seconds
6 years ago
Start With The End In Mind. How to facilitate transfer from non-GMP to GMP Manufacturing
In this podcast, we interviewed Avril Vermunt, bioprocess hardware specialist at GE healthcare about transferring a process from a non-GMP to a GMP environment, particularly how resource-intensive it is for process development and manufacturing groups. Avril has several years of experience working in the technology transfer group at a large pharmaceutical company. We discussed with her best practices and how being proactive and one step ahead can make the process more seamless.
View show notes at downstreamcolumn.com/podcast/facilitate-transfer-from-non-gmp-to-gmp-manufacturing/
The Downstream Column Podcast
The Downstream Column (DsC) is an online publication targeting members of the biologics industry. Our intent is to provide a community to share expertise and best practices as well as discuss topics of interest. The Downstream Column covers areas important to the research, discovery, development, and manufacture of biologic therapeutics. Key industry coverage areas include: purification, formulation, fill/finish, and QA/QC for cell and gene therapies, vaccines, biologics, and emerging therapeutic modalities.
